Achieve Life Stock Forward View - Simple Regression
| ACHV Stock | USD 4.17 0.03 0.72% |
A well-timed prediction of Achieve Life's price direction can generate meaningful returns. This module uses sentiment and hype analysis rather than traditional financial modeling to project probable near-term price movement.
As of 15th of March 2026, RSI for Achieve Life stands at 46, indicating moderately negative momentum. This mild bearish tilt suggests sellers have a slight edge, though the reading is well above levels that would indicate panic.Momentum
Impartial
Oversold | Overbought |
Hype-based context for Achieve Life Sciences connects recent headlines with price response and peer activity.
The Simple Regression forecasted value of Achieve Life Sciences on the next trading day is expected to be 4.27 with a mean absolute deviation of 0.38 and the sum of the absolute errors of 23.36.Achieve Life after-hype prediction price | $ 4.17 |
Attention metrics here are presented with forecasting, technical, analyst, and earnings context.
Use Historical Fundamental Analysis of Achieve Life to cross-verify projections for Achieve Life. The analysis adds historical context for the projection set.Achieve Life Additional Predictive Modules
Most predictive techniques to examine Achieve price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Achieve using various technical indicators. When you analyze Achieve charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Simple Regression Price Forecast For the 16th of March 2026
Given 90 days horizon, the Simple Regression forecasted value of Achieve Life Sciences on the next trading day is expected to be 4.27 with a mean absolute deviation of 0.38 , mean absolute percentage error of 0.22 , and the sum of the absolute errors of 23.36 .Please note that although there have been many attempts to predict Achieve Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Achieve Life's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Achieve Life | Achieve Life Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Achieve Life Sciences uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Achieve Life stock data series using in forecasting. Note that when a statistical model is used to represent Achieve Life stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.5855 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3829 |
| MAPE | Mean absolute percentage error | 0.0801 |
| SAE | Sum of the absolute errors | 23.3557 |
Experienced investors tracking Achieve Life's watch for mean reversion setups: periods when price has deviated significantly from its long-run average, creating an asymmetric risk-reward profile for patient capital.
After-Hype Price Density Analysis
The after-hype price distribution for Achieve Life reflects the range of predicted outcomes based on historical news impact analysis. The spread of Achieve Life's distribution is a direct measure of the uncertainty inherent in any forward-looking price model.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The after-hype price boundaries for Achieve Life are calculated from a database of Achieve Life's historical headline events and subsequent daily price movements. Achieve Life's after-hype downside and upside margins for the prediction period are 0.42 and 7.92, respectively. Investors should treat these as statistical reference points, not precise predictions for Achieve Life.
Current Value
Macroaxis estimates the after-hype price of Achieve Life Sciences across a 3 months horizon to evaluate where the instrument could settle once headline distortion subsides. Used correctly, the estimate adds context around potential normalization rather than promising a specific realized outcome.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Achieve Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Achieve Life backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Achieve Life, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.05 | 3.75 | 0.00 | 0.00 | 0 Events | 0 Events | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.17 | 4.17 | 0.00 |
|
Hype Timeline
Achieve Life Sciences is presently traded for 4.17. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Achieve is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.05%. %. The volatility of related hype on Achieve Life is about 0.0%, with the expected price after the next announcement by competition of 4.17. About 47.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.35. Achieve Life Sciences had its last dividend issued on the 31st of July 2020. The company completed a 1:20 stock split on 31st of July 2020. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Use Historical Fundamental Analysis of Achieve Life to cross-verify projections for Achieve Life. The analysis adds historical context for the projection set.Related Hype Analysis
Peer hype analysis for Achieve Life aggregates sentiment and news impact data from Achieve Life's competitive set to identify sector-wide trends before they are fully reflected in Achieve Life's own price.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TRDA | Entrada Therapeutics | 0.00 | 0 per month | 3.20 | 0.09 | 6.40 | -6.72 | 14.87 | |
| VNDA | Vanda Pharmaceuticals | 0.00 | 0 per month | 5.04 | 0.1 | 10.01 | -6.46 | 49.80 | |
| HUMA | Humacyte | 0.00 | 0 per month | 4.58 | 0.03 | 11.11 | -7.29 | 43.72 | |
| VYGR | Voyager Therapeutics | 0.00 | 0 per month | 3.34 | 0.04 | 5.59 | -5.35 | 30.07 | |
| AVIR | Atea Pharmaceuticals | 0.00 | 0 per month | 1.51 | 0.33 | 8.20 | -2.91 | 17.79 | |
| ARCT | Arcturus Therapeutics Holdings | 0.00 | 0 per month | 0.00 | -0.01 | 6.13 | -5.23 | 17.23 | |
| ALLO | Allogene Therapeutics | 0.00 | 0 per month | 4.57 | 0.16 | 11.11 | -7.79 | 28.70 | |
| CAPR | Capricor Therapeutics | 0.00 | 0 per month | 3.86 | 0.08 | 9.04 | -6.69 | 22.92 | |
| SGMT | Sagimet Biosciences Series | 0.00 | 0 per month | 0.00 | -0.03 | 5.78 | -7.32 | 22.02 | |
| IMRX | Immuneering Corp | 0.00 | 0 per month | 8.44 | 0.02 | 8.12 | -4.93 | 67.18 |
Other Forecasting Options for Achieve Life
Investors evaluating Achieve at any level of experience must contend with the challenge of understanding Achieve Life's price movement. The presence of noise in Achieve Stock price charts can significantly complicate investment decisions.Achieve Life Related Equities
The following equities are related to Achieve Life within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Achieve Life against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Achieve Life Market Strength Events
For investors tracking Achieve Life Sciences, market strength indicators offer a quantitative way to evaluate how the stock behaves under varying market conditions. These metrics are widely used to refine market timing and identify the most favorable moments to trade Achieve Life.
Achieve Life Risk Indicators
Analyzing Achieve Life's basic risk indicators provides investors with a structured view of the risk-return trade-off associated with achieve stock. Forecasting Achieve Life's future price accurately requires understanding and quantifying the risks present in the investment.
| Mean Deviation | 3.01 | |||
| Standard Deviation | 3.75 | |||
| Variance | 14.05 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Achieve Life
The amount of media and story coverage tied to Achieve Life Sciences can signal where market attention is concentrating at the moment. A disciplined read of coverage helps investors separate durable relevance from temporary noise.
Contributor Headline
Latest Perspective From Macroaxis
Achieve Life Short Properties
Reviewing short-oriented indicators for Achieve Life Sciences is useful because long and short participants often create very different signals for timing and volatility. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 32.1 M | |
| Cash And Short Term Investments | 34.3 M |
Additional Tools for Achieve Stock Analysis
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |